The Development of a Domestic Violence Perpetrator Collusion Measurement Tool

Intimate Partner Violence (IPV) Clinical Trial

Official title:

Media, Public Health, and Colluding With Murder: The Development of a Domestic Violence Perpetrator Collusion Measurement Tool.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01942616
• Other study ID #: 0910005885
• Status: Completed
• Phase: N/A
• Start date: July 2009
• Est. completion date: January 2010

Study information

• Verified date: August 2023
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

We propose an experimental design to empirically establish the potential link between the media portrayal of DV and changes in an individual's DV descriptive and injunctive social norms. Specifically, this study will measure the degree to which people implicitly collude with DV perpetration.

Description:

Aim 1: To determine the impact of media "frames," "labeling," and "information inclusion" on "implicit collusion" with a DV perpetrator.

Hypotheses: Consumers exposed to media reports using "thematic frames" will be less likely to implicitly collude with perpetrators than those exposed to "episodic frames." Consumers exposed to DVH news stories labeled as "domestic violence" will be less likely to implicitly collude with perpetrators than consumers exposed to news stories labeled as "assault." Implicit collusion will correlate positively with the addition of non-relevant perpetrator "humanizing" characteristics. Consumers given negative information about the victim of DVH will be more likely to implicitly collude with the perpetrator than consumers given negative information about the perpetrator.

Aim 2: To determine how media portrayals of domestic violence impact descriptive and injunctive norms about domestic violence and, ultimately, drive implicit collusion with perpetrators.

Hypotheses: Controlling for individual pre-existing attitudes and social norms, consumers exposed to thematic frames or the label of DV will be less likely to shift their norms in a way that supports DV than those exposed to episodic frames or the label of assault. Consumers provided negative victim information or non-relevant characteristics that humanize the perpetrator will be more likely to shift their norms to accept DV.

Exploratory Aim: To identify racial/ethnic, gender, age, and regional differences in DV social norms.

Hypothesis: The media will differentially impact subpopulation DV attitudes, social norms and implicit collusion.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 72
• Est. completion date: January 2010
• Est. primary completion date: January 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Members of the public who are 18 years or older, who identify as White or African American or Hispanic.

Exclusion Criteria:

• Members of the public will be excluded if they are unable to read or understand English.

Related Conditions & MeSH terms

• Intimate Partner Violence (IPV)

Intervention

Other:
• Condition 1: Perpetrator Positive
Condition 1 frames the event as episodic, labels the event as domestic violence, uses a positive description of the perpetrator, and a negative description of the victim.
• Condition 2: Perpetrator Negative
The condition 2 intervention/exposure frames the event as thematic, labels the event as assault, uses a neutral description of the perpetrator, and a negative description of the perpetrator.
• Condition 3: Placebo
This intervention provides no details for the participant and is for comparison use in the study.

Locations

Country	Name	City	State
United States	Michigan State University	East Lansing	Michigan
United States	Michigan Department of Community Health	Lansing	Michigan
United States	Yale University	New Haven	Connecticut
United States	Loyola University New Orleans	New Orleans	Louisiana

Sponsors (1)

Lead Sponsor	Collaborator
Yale University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from Baseline on The Collusion Framing Subscale	The scale will be developed based on the changes from baseline.	The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Primary	Change from Baseline on The Collusion Labeling Subscale	The scale will be developed based on the changes from baseline.	The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Primary	Change from Baseline on The Collusion Extraneous Information Subscale	The scale will be developed based on the changes from baseline.	The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Primary	Change from Baseline on The Collusion Negative Characteristics Subscale	The scale will be developed based on the changes from baseline.	The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.